IPAS158
Concessão de registro
01/16/2024
RPI 2767
IPAS158 | Concessão de registro | RPI 2767 | Data 2024-01-16
Back to search
Official data from INPI
Fórmuly Pharma
Did you know this trademark is already registered in Brazil?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Concessão de registroType: CombinedOffice: BR
Quick snapshot
ST13
BR500000928118061Class
44
Filing
928118061
Registration
928118061
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Concessão de registro
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
09/23/2022
Registration date
01/16/2024
Expiration date
01/16/2034
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Holders and representatives
Holders
DÓREA COMÉRCIO E FARMÁCIA DE MANIPULAÇÃO LTDA
Representatives
MÍRIAN BARRETO LELIS STRAUCH BATISTA
****642****
Technical classification
Nice Classes
Class 44
Vienna Codes
27.5.1
Goods and services
Class 44
Análise farmacêutica;Assessoria, consultoria e informação sobre cuidados médicos;Aviamento de receita em farmácia de manipulação;Consultoria em farmacêutica;Farmácia de manipulação [manipulação de medicamentos];Manipulação de fórmulas medicinais;Preparação de receitas por farmacêuticos;
Publications
History of INPI decisions and trademark events.
3 publications found
IPAS029
Deferimento do pedido
12/05/2023
RPI 2761
IPAS029 | Deferimento do pedido | RPI 2761 | Data 2023-12-05
IPAS009
Publicação de pedido de registro para oposição (exame formal concluído)
10/11/2022
RPI 2701
IPAS009 | Publicação de pedido de registro para oposição (exame formal concluído) | RPI 2701 | Data 2022-10-11
Continuous trademark protection
Get notified about every new filing that threatens Fórmuly Pharma or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.